Literature DB >> 31614208

Intracrinology-revisited and prostate cancer.

Trevor M Penning1, Andrea J Detlefsen2.   

Abstract

The formation of steroid hormones in peripheral target tissues is referred to as their intracrine formation. This process occurs in hormone dependent malignancies such as prostate and breast cancer in which the disease can be either castrate resistant or occur post-menopausally, respectively. In these instances, the major precursor steroid of androgens and estrogens is dehydroepiandrosterone (DHEA) and DHEA-SO4. This article reviews the major pathways by which adrenal steroids are converted to the potent male sex hormones, testosterone (T) and 5α-dihydrotestosterone (5α-DHT) and the discrete enzyme isoforms involved in castration resistant prostate cancer. Previous studies have mainly utilized radiotracers to investigate these pathways but have not used prevailing concentrations of precursors found in castrate male human serum. In addition, the full power of stable-isotope dilution liquid chromatography tandem mass spectrometry has not been applied routinely. Furthermore, it is clear that adaptive responses occur in the transporters and enzyme isoforms involved in response to androgen deprivation therapy that need to be considered.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Abiraterone acetate; Aldo-Keto reductase; Androgen receptor; Androgens; Bicalutamide; Castration resistant prostate cancer; Enzalutamide; Hydroxysteroid dehydrogenase; Leuprolide; Steroid 5α-reductase

Mesh:

Substances:

Year:  2019        PMID: 31614208      PMCID: PMC6954292          DOI: 10.1016/j.jsbmb.2019.105499

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  102 in total

1.  Inhibition of testicular 17 alpha-hydroxylase and 17,20-lyase but not 3 beta-hydroxysteroid dehydrogenase-isomerase or 17 beta-hydroxysteroid oxidoreductase by ketoconazole and other imidazole drugs.

Authors:  M Ayub; M J Levell
Journal:  J Steroid Biochem       Date:  1987-11       Impact factor: 4.292

2.  Adrenal-derived 11-oxygenated 19-carbon steroids are the dominant androgens in classic 21-hydroxylase deficiency.

Authors:  Adina F Turcu; Aya T Nanba; Robert Chomic; Sunil K Upadhyay; Thomas J Giordano; James J Shields; Deborah P Merke; William E Rainey; Richard J Auchus
Journal:  Eur J Endocrinol       Date:  2016-02-10       Impact factor: 6.664

3.  Activation of the androgen receptor by intratumoral bioconversion of androstanediol to dihydrotestosterone in prostate cancer.

Authors:  James L Mohler; Mark A Titus; Suxia Bai; Brian J Kennerley; Fred B Lih; Kenneth B Tomer; Elizabeth M Wilson
Journal:  Cancer Res       Date:  2011-02-08       Impact factor: 12.701

4.  Inhibition of steryl sulfatase activity in LNCaP human prostate cancer cells.

Authors:  Kyle W Selcer; Heidi Kabler; Jennifer Sarap; Zili Xiao; Pui-Kai Li
Journal:  Steroids       Date:  2002-09       Impact factor: 2.668

5.  Evidence of limited contributions for intratumoral steroidogenesis in prostate cancer.

Authors:  Johannes Hofland; Wytske M van Weerden; Natasja F J Dits; Jacobie Steenbergen; Geert J L H van Leenders; Guido Jenster; Fritz H Schröder; Frank H de Jong
Journal:  Cancer Res       Date:  2010-01-19       Impact factor: 12.701

6.  ERG/AKR1C3/AR Constitutes a Feed-Forward Loop for AR Signaling in Prostate Cancer Cells.

Authors:  Katelyn Powell; Louie Semaan; M Katie Conley-LaComb; Irfan Asangani; Yi-Mi Wu; Kevin B Ginsburg; Julia Williams; Jeremy A Squire; Krishna R Maddipati; Michael L Cher; Sreenivasa R Chinni
Journal:  Clin Cancer Res       Date:  2015-03-09       Impact factor: 12.531

7.  Characteristics of human types 1, 2 and 3 17 beta-hydroxysteroid dehydrogenase activities: oxidation/reduction and inhibition.

Authors:  V Luu-The; Y Zhang; D Poirier; F Labrie
Journal:  J Steroid Biochem Mol Biol       Date:  1995-12       Impact factor: 4.292

8.  Increased expression of genes converting adrenal androgens to testosterone in androgen-independent prostate cancer.

Authors:  Michael Stanbrough; Glenn J Bubley; Kenneth Ross; Todd R Golub; Mark A Rubin; Trevor M Penning; Phillip G Febbo; Steven P Balk
Journal:  Cancer Res       Date:  2006-03-01       Impact factor: 12.701

9.  The effect of allelic variation in aldo-keto reductase 1C2 on the in vitro metabolism of dihydrotestosterone.

Authors:  Ryan H Takahashi; Thomas A Grigliatti; Ronald E Reid; K Wayne Riggs
Journal:  J Pharmacol Exp Ther       Date:  2009-03-03       Impact factor: 4.030

10.  Role of OATP transporters in steroid uptake by prostate cancer cells in vivo.

Authors:  S M Green; A Kaipainen; K Bullock; A Zhang; J M Lucas; C Matson; W A Banks; E A Mostaghel
Journal:  Prostate Cancer Prostatic Dis       Date:  2016-09-20       Impact factor: 5.554

View more
  3 in total

Review 1.  The Role of Kisspeptin in the Control of the Hypothalamic-Pituitary-Gonadal Axis and Reproduction.

Authors:  Qinying Xie; Yafei Kang; Chenlu Zhang; Ye Xie; Chuxiong Wang; Jiang Liu; Caiqian Yu; Hu Zhao; Donghui Huang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-28       Impact factor: 6.055

Review 2.  Determination of Intraprostatic and Intratesticular Androgens.

Authors:  Markéta Šimková; Jiří Heráček; Pavel Drašar; Richard Hampl
Journal:  Int J Mol Sci       Date:  2021-01-05       Impact factor: 5.923

3.  Comprehensive Sex Steroid Profiling in Multiple Tissues Reveals Novel Insights in Sex Steroid Distribution in Male Mice.

Authors:  Hannah Colldén; Maria E Nilsson; Anna-Karin Norlén; Andreas Landin; Sara H Windahl; Jianyao Wu; Karin L Gustafsson; Matti Poutanen; Henrik Ryberg; Liesbeth Vandenput; Claes Ohlsson
Journal:  Endocrinology       Date:  2022-03-01       Impact factor: 4.736

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.